Ovid Therap (OVID.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Event Tracking

Nov14

BTIG Maintains Buy Rating on Ovid, Oppenheimer Cuts to Buy

11:21

Nov13

Ovid Therap released FY2025 Q3 earnings on November 12 (EST), actual revenue USD 132 K (forecast USD 170.38 K), actual EPS USD -0.1709 (forecast USD -0.15)

04:00

Ovid Therap released FY2025 9 Months Earnings on November 12, 2025 (EST) with actual revenue of USD 6.534 M and EPS of USD -0.3772

04:00

Oct27

Ovid Therapeutics Inc. to Hold Special Meeting for Voting on Amending the Restated Certificate of Incorporation Proposal

21:30

Oct9

Analyst Olson Covers Ovid Therapeutics

07:56

Oct3

Minter Analysts Show Good Performance in Recommended Healthcare Stocks

16:46

Schedules & Filings

Schedules

Filings

Nov12

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 132 K, Net Income -12.16 M, EPS -0.1709

Aug13

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 6.272 M, Net Income -4.603 M, EPS -0.0647

May13

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 130 K, Net Income -10.06 M, EPS -0.1415

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change